Analysts expect CollPlant Holdings Ltd. (NASDAQ:CLGN) to report $-0.54 EPS on March, 20.They anticipate $0.05 EPS change or 8.47% from last quarter’s $-0.59 EPS. After having $0.29 EPS previously, CollPlant Holdings Ltd.’s analysts see -286.21% EPS growth. The stock decreased 3.47% or $0.18 during the last trading session, reaching $5. About 6,002 shares traded. CollPlant Holdings Ltd. (NASDAQ:CLGN) has 0.00% since February 18, 2018 and is . It has by 0.00% the S&P500.
Owens & Minor Inc (NYSE:OMI) had a decrease of 36.33% in short interest. OMI’s SI was 6.49M shares in February as released by FINRA. Its down 36.33% from 10.20M shares previously. With 1.60M avg volume, 4 days are for Owens & Minor Inc (NYSE:OMI)’s short sellers to cover OMI’s short positions. The SI to Owens & Minor Inc’s float is 10.68%. The stock increased 1.99% or $0.15 during the last trading session, reaching $7.7. About 1.14 million shares traded. Owens & Minor, Inc. (NYSE:OMI) has declined 61.35% since February 18, 2018 and is downtrending. It has underperformed by 61.35% the S&P500. Some Historical OMI News: 18/04/2018 – OWENS & MINOR CUT TO TO BB FROM BB+ BY FITCH; 10/04/2018 – Owens & Minor at Deutsche Bank Health Care Conference May 9; 01/05/2018 – S&PGR Downgrades Owens & Minor To ‘BB’; Outlook Negative; 17/05/2018 – Terrell Owens goes for Jason Garrett’s head; 07/03/2018 – U.S. HEALTH CARE SERVICES: BARCLAYS SAYS LEAST POSITIVE ON MEDICAL/DENTAL DISTRIBUTORS; 18/04/2018 – FITCH DOWNGRADES OWENS & MINOR, INC.’S IDR TO ‘BB’; PLACES ON R; 10/05/2018 – Owens & Minor Presenting at Conference May 15; 16/04/2018 – LAUNCH: Owens & Minor 7Y TLB for Halyard Health Acq; Mtg 4/18; 08/05/2018 – Owens & Minor at Deutsche Bank Health Care Conference Tomorrow; 17/04/2018 – Moody’s Downgrades Owens & Minor’s Cfr To B1; Outlook Stable
Investors sentiment increased to 1.06 in Q3 2018. Its up 0.02, from 1.04 in 2018Q2. It increased, as 28 investors sold Owens & Minor, Inc. shares while 56 reduced holdings. 29 funds opened positions while 60 raised stakes. 53.93 million shares or 0.80% more from 53.50 million shares in 2018Q2 were reported. State Board Of Administration Of Florida Retirement System stated it has 38,899 shares or 0% of all its holdings. Gamco Investors Et Al invested in 170,450 shares. 12,000 were accumulated by Court Place Advisors Limited Liability Co. Dupont Mngmt holds 0.02% or 68,624 shares in its portfolio. Schwab Charles Mngmt has invested 0.01% of its portfolio in Owens & Minor, Inc. (NYSE:OMI). Invesco invested 0.01% in Owens & Minor, Inc. (NYSE:OMI). Signaturefd Ltd stated it has 39 shares or 0% of all its holdings. Qs Ltd Liability Corp reported 9,760 shares. California State Teachers Retirement reported 105,541 shares stake. Thrivent For Lutherans owns 43,130 shares for 0% of their portfolio. Moreover, Nj State Employees Deferred Compensation Plan has 0.04% invested in Owens & Minor, Inc. (NYSE:OMI) for 16,000 shares. Moreover, Prentiss Smith & Co has 0.03% invested in Owens & Minor, Inc. (NYSE:OMI) for 3,375 shares. Stratos Wealth Prns Ltd accumulated 36 shares or 0% of the stock. Ubs Asset Mngmt Americas Incorporated stated it has 0% of its portfolio in Owens & Minor, Inc. (NYSE:OMI). Deutsche Bank & Trust Ag invested 0% of its portfolio in Owens & Minor, Inc. (NYSE:OMI).
Among 3 analysts covering Owens u0026 Minor (NYSE:OMI), 0 have Buy rating, 1 Sell and 2 Hold. Therefore 0 are positive. Owens u0026 Minor had 3 analyst reports since November 1, 2018 according to SRatingsIntel. Barclays Capital maintained Owens & Minor, Inc. (NYSE:OMI) on Thursday, November 1 with “Underweight” rating. The company was maintained on Thursday, January 3 by Bank of America.
Since August 20, 2018, it had 0 insider purchases, and 1 sale for $185,614 activity. COLPO CHARLES C also sold $185,614 worth of Owens & Minor, Inc. (NYSE:OMI) shares. Marlatt Geoff Taylor also sold $185,559 worth of Owens & Minor, Inc. (NYSE:OMI) shares. $165,857 worth of Owens & Minor, Inc. (NYSE:OMI) was sold by DAVIS ERIKA T on Tuesday, August 21.
More notable recent Owens & Minor, Inc. (NYSE:OMI) news were published by: Seekingalpha.com which released: “Dividend Cut, What Do I Do? – Seeking Alpha” on February 14, 2019, also Globenewswire.com with their article: “Report: Exploring Fundamental Drivers Behind Realty Income, United Therapeutics, NxStage Medical, PTC Therapeutics, AVEO Pharmaceuticals, and Owens & Minor â€” New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” published on January 28, 2019, Seekingalpha.com published: “Owens & Minor Doesn’t Have An Answer – Seeking Alpha” on November 19, 2018. More interesting news about Owens & Minor, Inc. (NYSE:OMI) were released by: Seekingalpha.com and their article: “Owens & Minor: Equity Investors Say ‘Yeah’, Creditors Say ‘Yikes!’ – Seeking Alpha” published on August 20, 2018 as well as Seekingalpha.com‘s news article titled: “New chairman at Owens & Minor – Seeking Alpha” with publication date: November 08, 2018.
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare services firm in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. The company has market cap of $479.47 million. The firm operates through three divisions: Domestic, International, and Clinical & Procedural Solutions. It currently has negative earnings. It offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.
More notable recent CollPlant Holdings Ltd. (NASDAQ:CLGN) news were published by: Streetinsider.com which released: “CollPlant (CLGN) Appoints Jonathan MN Rigby as Board Chairman – StreetInsider.com” on February 04, 2019, also Benzinga.com with their article: “35 Stocks Moving In Friday’s Mid-Day Session – Benzinga” published on January 25, 2019, Seekingalpha.com published: “CollPlant and United Therapeutics ink deal for 3D bioprinting of solid-organ scaffolds for human transplants; CLGN up 37% premarket – Seeking Alpha” on October 22, 2018. More interesting news about CollPlant Holdings Ltd. (NASDAQ:CLGN) were released by: Seekingalpha.com and their article: “Tilray and Equillium among healthcare gainers; ContraFect and Diffusion Pharmaceuticals among losers – Seeking Alpha” published on December 18, 2018 as well as Benzinga.com‘s news article titled: “30 Stocks Moving In Monday’s Pre-Market Session – Benzinga” with publication date: October 22, 2018.
CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. The company has market cap of $19.07 million. The Company’s products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. It currently has negative earnings. The company’s products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs.